鉴定CKAP2作为预防胃癌进展的潜在目标:一项多omics研究
Xueyi Liu1,2, Wenyu Zhang1, Hui Wang3
1Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China.
International journal of molecular sciences
|February 26, 2025
概括
细胞骨相关蛋白2 (CKAP2) 显示出作为胃癌 (GC) 生物标志物的潜力. 较高的CKAP2表达与较低的GC风险和更好的预后有关,表明其诊断和预后价值.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 胃癌 (GC) 是全球领先的恶性瘤,晚期诊断阻碍了治疗疗效.
- 早期识别GC的生物标志物对于改善患者的治疗结果至关重要.
- 人们越来越认识到衰老对癌症进展的作用,像CKAP2这样的蛋白质与细胞分裂和衰老有关.
研究的目的:
- 调查与衰老相关的基因和GC之间的因果关系.
- 探索细胞骨相关蛋白2 (CKAP2) 在胃癌发育,诊断和预后方面的潜在作用和意义.
主要方法:
- 使用了综合生物信息学方法,分析了GTEx,GWAS目录,CellAge,TCGA,GEO,HPA和CTD的数据.
- 评估了CKAP2表达,其与GC风险的相关性,GC患者的差异表达,预后价值,遗传相关性,功能丰富和免疫细胞透.
- 使用CTD数据库探索了CKAP2和化学物质之间的潜在相互作用.
主要成果:
- 增加CKAP2的表达与患GC的风险降低有关.
- 在GC和正常组织之间观察到CKAP2的显著差异表达,GC的表达更高.
- CKAP2对GC具有诊断价值,更高的表达与更有利的预后相关.
- 免疫透分析揭示了CKAP2与瘤免疫微环境的关联.
结论:
- CKAP2在胃癌中发挥着重要作用,并显示出作为诊断和预后生物标志物的潜力.
- 对于其在GC管理中的应用,需要对CKAP2进行进一步的临床研究.
- 通过CTD数据库识别出一种潜在的小分子化合物,该化合物针对CKAP2.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
09:16Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
Published on: February 5, 2018
6.2K
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K